246 related articles for article (PubMed ID: 16304161)
1. High-throughput assays using a luciferase-expressing replicon, virus-like particles, and full-length virus for West Nile virus drug discovery.
Puig-Basagoiti F; Deas TS; Ren P; Tilgner M; Ferguson DM; Shi PY
Antimicrob Agents Chemother; 2005 Dec; 49(12):4980-8. PubMed ID: 16304161
[TBL] [Abstract][Full Text] [Related]
2. Potential high-throughput assay for screening inhibitors of West Nile virus replication.
Lo MK; Tilgner M; Shi PY
J Virol; 2003 Dec; 77(23):12901-6. PubMed ID: 14610212
[TBL] [Abstract][Full Text] [Related]
3. Discovery of small molecule inhibitors of West Nile virus using a high-throughput sub-genomic replicon screen.
Gu B; Ouzunov S; Wang L; Mason P; Bourne N; Cuconati A; Block TM
Antiviral Res; 2006 Jun; 70(2):39-50. PubMed ID: 16724398
[TBL] [Abstract][Full Text] [Related]
4. Construction of self-replicating subgenomic West Nile virus replicons for screening antiviral compounds.
Alcaraz-Estrada SL; Reichert ED; Padmanabhan R
Methods Mol Biol; 2013; 1030():283-99. PubMed ID: 23821276
[TBL] [Abstract][Full Text] [Related]
5. Generation and characterization of West Nile pseudo-infectious reporter virus for antiviral screening.
Zhang HL; Ye HQ; Deng CL; Liu SQ; Shi PY; Qin CF; Yuan ZM; Zhang B
Antiviral Res; 2017 May; 141():38-47. PubMed ID: 28202375
[TBL] [Abstract][Full Text] [Related]
6. Triaryl pyrazoline compound inhibits flavivirus RNA replication.
Puig-Basagoiti F; Tilgner M; Forshey BM; Philpott SM; Espina NG; Wentworth DE; Goebel SJ; Masters PS; Falgout B; Ren P; Ferguson DM; Shi PY
Antimicrob Agents Chemother; 2006 Apr; 50(4):1320-9. PubMed ID: 16569847
[TBL] [Abstract][Full Text] [Related]
7. Adaptation of West Nile virus replicons to cells in culture and use of replicon-bearing cells to probe antiviral action.
Rossi SL; Zhao Q; O'Donnell VK; Mason PW
Virology; 2005 Jan; 331(2):457-70. PubMed ID: 15629788
[TBL] [Abstract][Full Text] [Related]
8. High-throughput screening for the identification of small-molecule inhibitors of the flaviviral protease.
Balasubramanian A; Manzano M; Teramoto T; Pilankatta R; Padmanabhan R
Antiviral Res; 2016 Oct; 134():6-16. PubMed ID: 27539384
[TBL] [Abstract][Full Text] [Related]
9. Characterization of an efficient dengue virus replicon for development of assays of discovery of small molecules against dengue virus.
Yang CC; Tsai MH; Hu HS; Pu SY; Wu RH; Wu SH; Lin HM; Song JS; Chao YS; Yueh A
Antiviral Res; 2013 May; 98(2):228-41. PubMed ID: 23499649
[TBL] [Abstract][Full Text] [Related]
10. Identification of a small-molecule inhibitor of dengue virus using a replicon system.
Hsu YC; Chen NC; Chen PC; Wang CC; Cheng WC; Wu HN
Arch Virol; 2012 Apr; 157(4):681-8. PubMed ID: 22249364
[TBL] [Abstract][Full Text] [Related]
11. A high-throughput assay using dengue-1 virus-like particles for drug discovery.
Qing M; Liu W; Yuan Z; Gu F; Shi PY
Antiviral Res; 2010 May; 86(2):163-71. PubMed ID: 20153777
[TBL] [Abstract][Full Text] [Related]
12. Functional analysis of mosquito-borne flavivirus conserved sequence elements within 3' untranslated region of West Nile virus by use of a reporting replicon that differentiates between viral translation and RNA replication.
Lo MK; Tilgner M; Bernard KA; Shi PY
J Virol; 2003 Sep; 77(18):10004-14. PubMed ID: 12941911
[TBL] [Abstract][Full Text] [Related]
13. Development of a novel dicistronic reporter-selectable hepatitis C virus replicon suitable for high-throughput inhibitor screening.
Hao W; Herlihy KJ; Zhang NJ; Fuhrman SA; Doan C; Patick AK; Duggal R
Antimicrob Agents Chemother; 2007 Jan; 51(1):95-102. PubMed ID: 17060518
[TBL] [Abstract][Full Text] [Related]
14. Development of a cell-based high-throughput specificity screen using a hepatitis C virus-bovine viral diarrhea virus dual replicon assay.
O'Boyle DR; Nower PT; Lemm JA; Valera L; Sun JH; Rigat K; Colonno R; Gao M
Antimicrob Agents Chemother; 2005 Apr; 49(4):1346-53. PubMed ID: 15793110
[TBL] [Abstract][Full Text] [Related]
15. Development of a replicon cell line-based high throughput antiviral assay for screening inhibitors of Zika virus.
Li JQ; Deng CL; Gu D; Li X; Shi L; He J; Zhang QY; Zhang B; Ye HQ
Antiviral Res; 2018 Feb; 150():148-154. PubMed ID: 29288699
[TBL] [Abstract][Full Text] [Related]
16. Genetic systems of West Nile virus and their potential applications.
Shi PY
Curr Opin Investig Drugs; 2003 Aug; 4(8):959-65. PubMed ID: 14508880
[TBL] [Abstract][Full Text] [Related]
17. Construction and characterization of a stable subgenomic dengue virus type 2 replicon system for antiviral compound and siRNA testing.
Ng CY; Gu F; Phong WY; Chen YL; Lim SP; Davidson A; Vasudevan SG
Antiviral Res; 2007 Dec; 76(3):222-31. PubMed ID: 17662475
[TBL] [Abstract][Full Text] [Related]
18. Identification of novel small-molecule inhibitors of West Nile virus infection.
Noueiry AO; Olivo PD; Slomczynska U; Zhou Y; Buscher B; Geiss B; Engle M; Roth RM; Chung KM; Samuel M; Diamond MS
J Virol; 2007 Nov; 81(21):11992-2004. PubMed ID: 17715228
[TBL] [Abstract][Full Text] [Related]
19. Identification and characterization of inhibitors of West Nile virus.
Puig-Basagoiti F; Qing M; Dong H; Zhang B; Zou G; Yuan Z; Shi PY
Antiviral Res; 2009 Jul; 83(1):71-9. PubMed ID: 19501258
[TBL] [Abstract][Full Text] [Related]
20. Sultam thiourea inhibition of West Nile virus.
Barklis E; Still A; Sabri MI; Hirsch AJ; Nikolich-Zugich J; Brien J; Dhenub TC; Scholz I; Alfadhli A
Antimicrob Agents Chemother; 2007 Jul; 51(7):2642-5. PubMed ID: 17452483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
